Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited TABLE 1 PRINCIPLE-WISE (AS PER NVGS) BR POLICY/POLICIES (REPLY IN Y/N) SR. NO. PRINCIPLE-WISE (AS PER NVGS) BR POLICY/POLICIES (REPLY IN Y/N) 7 Has the policy been formally communicated to all relevant internal and external stakeholders? P1 ETHICS, TRANSPARENCY AND ACCOUNTABILITY P2 PRODUCT LIFE CYCLE Yes Employees are required to sign an undertaking, at least annually, stating that they have read the Code of Business Ethics (COBE) and comply with the principles of the Code. New employees are required to sign a similar undertaking at the time of joining. Additionally, all our policies with respect to the nine principles our available on the Company website. P3 EMPLOYEE WELL- BEING Yes, all policies have been communicated to stakeholders. 8 Does the Company have in-house structure to implement the policy/policies? 9 Does the Company have a grievance redressal mechanism related to the policy/ policies to address stakeholders’ grievances related to the policy/ policies? 10 Has the company carried out independent audit/evaluation of the working of this policy by an internal or external agency? Yes Yes Yes, we have an intranet where all policies are published along with FAQs. Apart from that we have employee communication sent out on any changes in policies. Yes We also have a dedicated Ombudsperson Procedure to address all concerns related to Company-level policies. Yes We comply with the Nine Principles broadly through the following policies: Code of Business Conduct and Ethics (COBE), SHE Policy and Principles, Quality Policy, Purchase policy and HR policies. These policies are regularly reviewed by various internal and external agencies, including regulatory agencies. We also proactively follow public advocacy through various forums. Policy grievances are handled by the respective business HR partners. We also have a common email ID, wherein employees can drop an email with their feedback. All policies are audited by the internal audit team. We also have external auditors who review HR policies/ processes. P4 STAKEHOLDER ENGAGEMENT P5 HUMAN RIGHTS P6 ENVIRONMENT P7 POLICY ADVOCACY P8 EQUITABLE DEVELOPMENT P9 CUSTOMER VALUE Employees are required to sign an undertaking, at least annually, stating that they have read the Code of Business Ethics (COBE) and comply with the principles of the Code. New employees are required to sign a similar undertaking at the time of joining. Additionally, all our policies with respect to the nine principles our available on the Company website. Yes Yes Yes Yes Yes Yes Yes Yes Employees are required to sign an undertaking, at least annually, stating that they have read the Code of Business Ethics (COBE) and comply with the principles of the Code. New employees are required to sign a similar undertaking at the time of joining. Additionally, all our policies with respect to the nine principles our available on the Company website. We also have a dedicated Ombudsperson Procedure to address all concerns related to Company-level policies. Yes Yes NA NA We also have a dedicated Ombudsperson Procedure to address all concerns related to Company-level policies. We comply with the Nine Principles broadly through the following policies: Code of Business Conduct and Ethics (COBE), SHE Policy and Principles, Quality Policy, Purchase policy and HR policies. These policies are regularly reviewed by various internal and external agencies, including regulatory agencies. We also proactively follow public advocacy through various forums. Yes Yes No We comply with the Nine Principles broadly through the following policies: Code of Business Conduct and Ethics (COBE), SHE Policy and Principles, Quality Policy, Purchase policy and HR policies. These policies are regularly reviewed by various internal and external agencies, including regulatory agencies. We also proactively follow public advocacy through various forums. 30
Statutory Reports • Business Responsibility Report Annual Report 2014 - 15 80% yield Achieved through adopting an asymmetric reduction method for Eslicarbazepine acetate, compared to 50% yield before. Dr. A P J Abdul Kalam, former President of India, with scientists at IPDO SECTION E: PRINCIPLE-WISE PERFORMANCE PRINCIPLE 1 ETHICS, TRANSPARENCY AND ACCOUNTABILITY 1. Does the policy relating to ethics, bribery and corruption cover only the company? Yes/No. Does it extend to the Group/Joint Ventures/ Suppliers/Contractors/NGOs/ Others? The policy relating to ethics, bribery and corruption extends beyond our Company to the Group, our joint ventures, suppliers, contractors and the NGOs we partner with. 2. How many stakeholder complaints have been received in the past financial year and what percentage was satisfactorily resolved by the management? If so, provide details thereof, in about 50 words or so. We did not receive any significant stakeholder complaints in the last financial year. PRINCIPLE 2 PRODUCT LIFE CYCLE 1. List up to three of your products or services whose design has incorporated social or environmental concerns, risks and/or opportunities. Our following products help address social or environmental concerns in their design: i. Eslicarbazepine Acetate ii. Voriconazole iii. Pregabalin 2. For each such product, provide the following details in respect of resource use (energy, water, raw material etc.) per unit of product (optional): i. Reduction during sourcing/ production/distribution achieved since the previous year throughout the value chain? ii. Reduction during usage by consumers (energy, water) has been achieved since the previous year? 31
Page 1 and 2: ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4: Our Brand We are in the business of
Page 5 and 6: Corporate Overview Annual Report 20
Page 29 and 30: Statutory Reports • Business Resp
Page 31: Statutory Reports • Business Resp
Page 43 and 44: Statutory Reports • Management Di
Page 57 and 58: Statutory Reports • Corporate Gov
Page 73 and 74: Statutory Reports • Additional Sh
Page 83 and 84:
Statutory Reports • Additional Sh
Page 85 and 86:
Statutory Reports • Additional Sh
Page 87 and 88:
Statutory Reports • Board’s Rep
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Standalone Financial Statements Ann
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Consolidated Financial Statements A
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Notice Annual Report 2014 - 15 NOTI
Page 229 and 230:
E-Voting Annual Report 2014 - 15 IN
Page 231:
Dr. Reddy’s Laboratories Limited
Page 235 and 236:
The future belongs, not to those wh
show all

Good Health Can’t Wait.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?